Paediatric orthotopic heart transplant patients experience significant medical radiation exposure due to cardiac and non-cardiac imaging required pre- and post-transplant. Reference McDonnell, Downing, Zhu, Ryan, Rossano and Glatz1,Reference Noor, Shekhdar and Banner2 In a small cohort study, the mean cumulative effective dose is 53.5 millisieverts (∼1000 chest X-rays) in the first year after transplant; more than half is associated with cardiac catheterisation. Reference McDonnell, Downing, Zhu, Ryan, Rossano and Glatz1 Previous work by Congenital Cardiac Catheterization Outcomes Project-Quality Improvement Initiative showed the median dose for haemodynamics plus biopsy alone was 5 Gy*m2/kg (IQR 3–11 Gy*m2/kg), and for complete annual catheterisation with coronary angiography was 46 Gy*m2/kg (IQR 29–74 Gy*m2/kg). Reference Quinn, Armstrong and Bauser-Heaton3 This study was done in 2019, however, with older versions of fluoroscopic equipment. Therefore, it is important to examine strategies that reduce radiation exposure in this population while maintaining the ability to monitor haemodynamics using non-fluoroscopic techniques such as cardiac magnetic resonance. Reference Smith, Dorfman and Yu4,Reference Pollack, Nazif, Mancini and Weisz5
Cardiac magnetic resonance is increasingly used as a radiation-free way to identify rejection in cardiac transplant patients with multiple modalities undergoing investigation. Reference Olymbios, Kwiecinski, Berman and Kobashigawa6–Reference Sethi, Doshi and Doshi8 Cardiac magnetic resonance can be used to characterise tissue oedema, scar, perfusion defects, and quantify function more accurately than echocardiography alone. Reference Campbell-Washburn, Tavallaei and Pop7,Reference Jaochim Nesser, Sugeng and Corsi9–Reference Guttman, Ozturk and Raval11 However, cardiac magnetic resonance measurements of cardiac output have not been compared to direct catheter-based haemodynamic measurements in paediatric orthotopic heart transplant patients nor has there been analysis of inter-reader reliability of cardiac magnetic resonance measurements in this population.
Interventional cardiac magnetic resonance can collect a wealth of anatomic and physiologic data under one anaesthesia. The first description of interventional cardiac magnetic resonance is from 2004 with a group of adult and paediatric patients. The cardiac magnetic resonance data were collected simultaneously with invasive haemodynamics with good agreement. Reference Muthurangu, Taylor and Andriantsimiavona12 The largest interventional cardiac magnetic resonance feasibility study in children came in 2017 in 50 children and was followed in the same year by a larger study in 102 adults demonstrating good agreement between the two modalities. Reference Ratnayaka, Kanter and Faranesh13,Reference Rogers, Ratnayaka and Khan14 Follow-up studies have confirmed its utility in various physiologic states. Reference Arar, Hussain and Abou Zahr15 In certain patient populations, however, the specific anatomy and/or physiology may lead to significant disagreement between the two modalities. Reference Downing, Whitehead and Dori16,Reference Schäfer, Truong and Browne17 Some of the studies also had sequential sampling; cardiac magnetic resonance first and then haemodynamics. The studies all varied in their anaesthetic technique and patient sizes, known to vastly affect haemodynamics.
The aim of this study is to compare cardiac output measurements from traditional cardiac catheterisation with fluoroscopic guidance to interventional cardiac magnetic resonance within a paediatric orthotopic heart transplant cohort to evaluate concordance between the modalities. The second aim is to measure radiation doses from fluoroscopic catheterisation on up-to-date equipment to show what would be avoided with interventional cardiac magnetic resonance.
Materials and methods
Prospective interventional cardiac magnetic resonance
In an institutional review board approved study, with consent/assent as required, paediatric heart transplant patients of any age referred for medically necessary cardiac catheteriaation underwent magentic resonance-guided right heart catheterisation under general anaesthesia in the interventional cardiac magnetic resonance suite at Children’s National, based on standard methods previously described. Reference Ratnayaka, Kanter and Faranesh13 Imaging was completed using a 1.5 T Aera (Siemens, Erlangen, German), including standard volumetry and flow measurements, with parameters tailored to patient size according to guidelines and lab standards. Reference Ratnayaka, Kanter and Faranesh13,Reference Fratz, Chung and Greil18,Reference Christopher, Quinn and Zoulfagharian19 Baseline interventional cardiac magnetic resonance imaging was followed by cardiac catheterisation in the interventional cardiac magnetic resonance suite using standard real-time imaging guidance to collect oximetry and pressure data. Reference Ratnayaka, Kanter and Faranesh13 Heart rates at the time of pulmonary artery sampling (which served as the mixed venous saturation) were used to find the assumed oxygen consumption. Reference LaFarge and Miettinen20 The interventional cardiac magnetic resonance lab was not equipped at the time of this study to perform thermodilution and the ventilator modules for measuring oxygen consumption are not interventional cardiac magnetic resonance compatible, thus the assumed oxygen consumption was used. Pulmonary vein saturations were assumed to be equal to systemic saturations as measured by either pulse oximetry or invasive arterial monitoring when available. The Fick equation was then used to calculate pulmonary and systemic blood flow. Cardiac volumes, flow rates in the ascending aorta and main pulmonary artery were measured using offline software (Medis Medical Imaging, Leiden, the Netherlands). Flow measurements were performed by cardiologists with expertise in cardiac magnetic resonance and interrater reliability was assessed by a blinded observer who measured flows in all cases.
Controls for radiation measurement
Contemporaneous heart transplant patients who underwent standard fluoroscopy-guided catheterisation between 2018 and 2020 provided data for radiation dose estimation. Single plane fluoroscopy and angiography procedures were performed in a single catheterisation suite with up-to-date equipment by two providers (Siemens Artis Q biplane and Zen biplane with large- and medium-sized detectors, respectively). Patients were excluded if they were critically ill (resulting in elevated procedure times) or had additional procedures requiring fluoroscopy outside of biopsy or coronary angiography. The demographics and total indexed dose area product were collected and then converted to Gy*m2/kg. Patients were then stratified into two groups: (1) follow-up for rejection with surveillance haemodynamics and (2) traditional complete annual catheterisation. Patients in the follow-up for rejection group had haemodynamics and endomyocardial biopsy under fluoroscopy. Complete annual catheterisation patients had haemodynamics, endomyocardial biopsy, and coronary angiography under fluoroscopy. A group with haemodynamics alone could not be retrospectively created with the current fluoroscopy equipment limiting full direct comparison.
Analysis
We used the Kolmogorov–Smirnov test to evaluate the normality assumption prior to conducting Bland–Altman and concordance analysis to compare cardiac magnetic resonance- and Fick-generated measurements of pulmonary and systemic blood flow using Stata (StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp, LLC). We also evaluated the correlation between differences in haemodynamic measurements from the same patients to determine whether repeat measurements could be treated as independent prior to Bland–Altman and concordance analysis. In these analyses, systemic blood flow was defined as total caval return when comparing cardiac magnetic resonance and Fick Qp. Pulmonary blood flow was defined as pulmonary venous return when comparing cardiac magnetic resonance and Fick Qs. These definitions were assigned recognising that aortopulmonary collateral flow may be present in those with single ventricle physiology prior to orthotopic heart transplant. In a subset of 67 patients with no significant valvular regurgitation, the concordance of cardiac magnetic resonance measures of pulmonary blood flow and systemic blood flow and right and left ventricular cardiac output was evaluated using Lin’s correlation coefficient.
Once Bland–Altman and concordance analyses were completed, a mixed-effects model was implemented to control for multiple clinical and demographic variables when evaluating paired differences between cardiac magnetic resonance and Fick measurements. Finally, interrater reliability for flow measurements was assessed using a two-tailed intraclass correlation coefficient.
Results
Hemodynamic agreement
Sixty-seven interventional cardiac magnetic resonance procedures in 28 unique heart transplant patients with usable cardiac magnetic resonance and catheterisation data were included in analysis (Table 1). Two studies were excluded due to inaccurate cardiac magnetic resonance triggering and image artifacts that compromised accuracy. The interventional cardiac magnetic resonance versus Fick group tended to be younger at time of transplant, but had longer time from transplant to procedure indicative of well-established grafts. Patients who had haemodynamics and endomyocardial biopsy alone tended to be newer transplants with multiple catheterisations performed in the first year. After validating the normality assumption and negligible effect of repeat assessments, Bland–Altman analysis for comparison of cardiac magnetic resonance and Fick measurements of cardiac had Lin correlation coefficients 0.68 and 0.73 for pulmonary blood flow and systemic blood flow, respectively. The bias for both datasets was + 0.5 L/min with 95% limits of agreement of −1.0 – + 2.1 for pulmonary blood flow and −0.9 – + 1.9 for systemic blood flow (Fig. 1, panels A, B). This indicates Fick consistently produces estimates of cardiac output that exceed cardiac magnetic resonance estimates by an average of 0.5 L/min. The R2 for both datasets was 0.6 (Fig. 1, panels C,D).
Accounting for haemoglobin using a mixed model linear regression analysis resulted in significant improvements in the correlation between cardiac magnetic resonance and Fick, particularly with anaemic patients; patient age, body surface area, and heart rate had minimal effect (Fig. 2). A sub-analysis of 9 patients with Fontan circulation was performed, and the presence of previous Fontan had little effect on the Bland–Altman analysis and correlation (bias + 0.5 L/min with 95% limits of agreement of −1.0 – + 2.0 with R2 of 0.6 for pulmonary blood flow and −1.1 – + 2.1 and R2 of 0.5 for systemic blood flow).
Cardiac magnetic resonance flow measurements were also compared to volumetry measurements of right ventricular cardiac output and left ventricular cardiac output in a sub-analysis of the original interventional cardiac magnetic resonance group from those providing usable volumetry data for both ventricles. In 66 cardiac magnetic resonances from 28 unique patients with no significant valve leak, Lin correlation coefficients of systemic blood flow (from phase contrast) and left ventricular cardiac output were 0.8, and for pulmonary blood flow (from phase contrast) and right ventricular cardiac output was 0.8, demonstrating good agreement between volumetry and flow measurements of cardiac output. For completeness, cardiac output data were compared to Fick and results correlated even less with Lin correlation coefficients of 0.5 for both pulmonary blood flow and systemic blood flow.
Finally, the two tailed interrater reliability for cardiac magnetic resonance pulmonary blood flow and systemic blood flow were 0.91 (95% confidence interval 0.86–0.94) and 0.95 (95% confidence interval 0.92–0.97), respectively, demonstrating excellent inter-rater agreement.
Radiation exposure
The contemporaneous cohort for radiation dose comparison consisted of 60 catheterisations, including 21 patients with 41 haemodynamic and endomyocardial biopsy procedures and 19 patients with 19 complete annual catheterisation procedures, with demographics listed in Table 1. The median ± interquartile range radiation dose for haemodynamics with endomyocardial biopsy (no coronary angiography) was 0.7 ± 0.6 Gy*m2/kg and for complete annual catheterisation, 14.6 ± 7.8 Gy*m2/kg (Fig. 3). Surveillance coronary angiography represented the dominant contributor to radiation dose during routine surveillance of the orthotopic heart transplant population.
Discussion
In the paediatric population, cardiac catheterisation is considered the gold standard for post-transplant haemodynamic surveillance, despite its inherent invasiveness and radiation exposure. These data demonstrate that cardiac magnetic resonance measures of flow and cardiac output volumes correlate well with each other, but there is less correlation with Fick. This is likely due to several assumptions required to utilise Fick, including Reference McDonnell, Downing, Zhu, Ryan, Rossano and Glatz1 assumed oxygen consumption, Reference Noor, Shekhdar and Banner2 temporal resolution of data sampling between cardiac magnetic resonance (which takes seconds to measure) and Fick (which relies on samples over a 5–10 minute period). Previous Fontan circulation did not account for the differences in Fick and cardiac magnetic resonance in a sub-analysis. Interestingly, there was a trend with haemoglobin such that the extremes of haemoglobin levels lead to even worse correlation between Fick and cardiac magnetic resonance which could be related to subtle differences in assumed oxygen consumption. cardiac magnetic resonance measures can be limited by flow dispersion from dephasing artifacts such as sternal wires, stents, and other metal implants and signal loss is also possible with turbulent flow leading to error. Direct oximetry and Fick equation, however, are limited by assumed oxygen consumption which come from free breathing, healthy subjects which does not fit a typical paediatric heart transplant catheterisation population. Cardiac magnetic resonance may be, perhaps, the more ideal modality in patients where assumed oxygen consumption and Fick is an even more poor measure. This would include children on beta blockers, those with sick sinus syndrome, and those with mixed pulmonary venous desaturations. Other studies have suggested there is good correlation between these modalities with similar populations, but ours has simultaneous measurements which limits variability due to time and anaesthesia. This work shows there is poor correlation between cardiac magnetic resonance and Fick, albeit on a small population. Further studies to correlate cardiac magnetic resonance measures of volume and flow with outcomes would increase its reliability, especially if Fick could not predict the same outcome.
This study shows the radiation exposure avoided by using interventional cardiac magnetic resonance for haemodynamic catheterisation and endomyocardial biopsy is negligible, as most of the radiation is delivered during coronary angiography. Although interventional cardiac magnetic resonance is an important start, impactful radiation exposure reduction would come from studying transplant related coronary artery vasculopathy with cardiac magnetic resonance. These are important steps in shifting surveillance for transplant rejection and transplant related coronary artery vasculopathy care away from invasive catheterisation toward Reference McDonnell, Downing, Zhu, Ryan, Rossano and Glatz1 non-invasive cardiac magnetic resonance. There is ongoing research to study rejection with cardiac magnetic resonance and interventional cardiac magnetic resonance, but it has been limited in children with fewer financial incentives. Reference Dolan, Rahsepar and Blaisdell21–Reference Rogers, Ratnayaka and Karmarkar23 Transplant-related cardiac allograft vasculopathy has been studied in children and adults with cardiac CT, myocardial perfusion reserve with cardiac magnetic resonance, and biomarkers including cell-free DNA with limited studies in children. Reference Wever-Pinzon, Romero and Kelesidis24–Reference Kindel, Hsu, Hussain, Johnson, McMahon and Kutty29 Financial and research investment in studying rejection and transplant-related cardiac allograft vasculopathy is an important step forward to limit ongoing radiation exposure for paediatric heart transplant recipients.
This study is limited in a few ways, including the size of the interventional cardiac magnetic resonance cohort. While large for the field, its size limits the ability to draw firm inferences in some areas including the effect of haemoglobin. There is also a noticeably lower age of children in the haemodynamics with endomyocardial biopsy radiation group because of an increase in transplants in patients under 1 year in recent years. These patients required multiple surveillance catheterisations the first year after transplantation leading to a lower average age of the group.
Conclusion
Our study shows cardiac magnetic resonance measurements of cardiac output are not concordant and cannot adequately reproduce those measured by invasive catheterisation. There is good correlation, however, between flow and volume measurements in cardiac magnetic resonance suggesting good internal validity. In some patients where the assumptions of the Fick equation are invalid, (e.g. mixed pulmonary venous desaturations, patients on beta blockers or with sick sinus syndrome, extremes of size, etc), cardiac magnetic resonance may correlate better with the patient’s physiology and outcome. Further study of this is needed. While cardiac magnetic resonance can provide catheter guidance and flow measurements without use of radiation, the radiation exposure avoided from a haemodynamic catheterisation alone is too small to be clinically meaningful when compared to the exposure from annual coronary angiography. Future multi-site work must concentrate on these opportunities for accurate diagnosis with cardiac magnetic resonance methods to reduce radiation exposure in this population.
Acknowledgements
Karin Hammin for aid in data requisition and monitoring.
Author contribution
JS and IC gathered data, JS analysed all data points in addition to JGM who performed ICC analysis, RSM performed all statistics, JS assembled the manuscript, remaining authors aided in editing.
Financial support
NHLBI R01HL144494-01.
Competing interests
None.
Ethics standard
Approved by Children’’s National Medical Center Institutional Review Board (IRB number 1140811,408).